Fortress Biotech: Q2 Earnings Insights

  Fortress Biotech (NASDAQ:FBIO) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

 

Fortress Biotech (NASDAQ:FBIO) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Fortress Biotech beat estimated earnings by 52.38%, reporting an EPS of $-0.1 versus an estimate of $-0.21.

Revenue was up $1.04 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.18 which was followed by a 7.29% increase in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Fortress Biotech visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Existing Home Sales At Lowest Point In 12 Years: How Will This Impact Opendoor Earnings?

Mortgage rates are back on the rise due to a strong performance in retail sales and labor market data, along with positive monthly inflation readings. This has raised the prospect of the Federal Reserve continuing its interest rate hiking campaign through the summer.

OPEN